1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Thriving Amidst Complexity: the Dynamics Within the Market of Parallel Imports of Pharmaceuticals in Sweden
(
- Master (Two yrs)
- 2022
-
Mark
Killer Acquisitions and EU Merger Control
(
- Master (Two yrs)
-
Mark
Reverse Payment Patent Settlements as Restrictions by Object under Article 101(1) TFEU
(
- Prof. qual. >4 yrs
-
Mark
Competing on sustainability - A study on stakeholder interaction, becoming truly sustainable and obtaining a sustained competitive advantage in an industry characterized by low sustainability maturity
(
- Master (Two yrs)
-
Mark
Coloniality in Intellectual Property Rights Legitimations: A Critical Discourse Analysis of The Pharmaceutical Industry’s Legitimation of Intellectual Property Rights During the COVID-19 Pandemic
(
- Master (Two yrs)
-
Mark
Sustainability Report in the context of pandemic from legitimacy theory and stakeholder theory perspective - A case study of Nordic Region Pharmaceutical companies
(
- Master (One yr)
- 2020
-
Mark
Pharming from A to Z
(
- Bach. Degree
- 2019
-
Mark
Determinants of Short-Term Value Creation through M&A for the Acquirer -The event study of the pharmaceutical industry focus on the Western European market
(
- Master (One yr)
- 2018
-
Mark
Reverse payment settlements in the context of Article 102 TFEU: Abusive or not? By object or not?
(
- Master (One yr)
-
Mark
Do Mergers and Acquisitions Create Value for Acquirers? Short- and Long-Term Event Study on the Pharmaceutical Industry of Europe
(
- Master (One yr)